Literature DB >> 5821624

Effect of aerosol propellants and surfactants on airway resistance.

G M Sterling, J C Batten.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5821624      PMCID: PMC471943          DOI: 10.1136/thx.24.2.228

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  16 in total

1.  Atropine methonitrate and isoprenaline in bronchial asthma.

Authors:  D A CHAMBERLAIN; D C MUIR; K P KENNEDY
Journal:  Lancet       Date:  1962-11-17       Impact factor: 79.321

2.  Airway resistance and peak expiratory flow-rate in smokers and non-smokers.

Authors:  N ZAMEL; H H YOUSSEF; F J PRIME
Journal:  Lancet       Date:  1963-06-08       Impact factor: 79.321

3.  Mechanism of bronchoconstriction during inhalation of dust.

Authors:  J G WIDDICOMBE; D C KENT; J A NADEL
Journal:  J Appl Physiol       Date:  1962-07       Impact factor: 3.531

4.  Evaluation of methods used in detecting changes of airway resistance in man.

Authors:  T C LLOYD; G W WRIGHT
Journal:  Am Rev Respir Dis       Date:  1963-04

5.  Acute effects of inhalation of cigarette smoke on airway conductance.

Authors:  J A NADEL; J H COMROE
Journal:  J Appl Physiol       Date:  1961-07       Impact factor: 3.531

6.  Physiological factors affecting airway resistance in normal subjects and in patients with obstructive respiratory disease.

Authors:  J BUTLER; C G CARO; R ALCALA; A B DUBOIS
Journal:  J Clin Invest       Date:  1960-04       Impact factor: 14.808

7.  The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size.

Authors:  W A BRISCOE; A B DUBOIS
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

8.  Mechanism of bronchoconstriction caused by cigarette smoking.

Authors:  G M Sterling
Journal:  Br Med J       Date:  1967-07-29

9.  Investigation into use of drugs preceding death from asthma.

Authors:  F E Speizer; R Doll; P Heaf; L B Strang
Journal:  Br Med J       Date:  1968-02-10

10.  A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.

Authors:  A B DUBOIS; S Y BOTELHO; J H COMROE
Journal:  J Clin Invest       Date:  1956-03       Impact factor: 14.808

View more
  10 in total

1.  Bronchial reactions to aerosol inhalant vehicle.

Authors:  D H Bryant; J Pepys
Journal:  Br Med J       Date:  1976-05-29

2.  Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes.

Authors:  T Engel; B Scharling; B Skovsted; J H Heinig
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 3.  Cough as an adverse effect on inhalation pharmaceutical products.

Authors:  Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Sussan Ghassabian; John D Brannan; Heikki O Koskela; Hak-Kim Chan
Journal:  Br J Pharmacol       Date:  2020-08-07       Impact factor: 8.739

4.  Advances in the understanding of asthma.

Authors: 
Journal:  West J Med       Date:  1979-01

5.  Clinical trials in asthma.

Authors:  J Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-06

6.  Occupational asthma due to heated freon.

Authors:  J L Malo; G Gagnon; A Cartier
Journal:  Thorax       Date:  1984-08       Impact factor: 9.139

7.  Bronchodilator action of inhaled fenoterol and ipratropium in normal subjects: a teaching exercise for medical students.

Authors:  R G Taylor; J Maclagan; D G Cook
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 8.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

9.  Effects of terbutaline sulphate aerosol on bronchodilator response and lung mucociliary clearance in patients with mild stable asthma.

Authors:  J R Bateman; D Pavia; N F Sheahan; S P Newman; S W Clarke
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

10.  Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis.

Authors:  M Kattan; A Mansell; H Levison; M Corey; I R Krastins
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.